FDA
-
-
-
-
-
-
-
Twist Bioscience Corporation (TWST) and Biotia Receive Expanded EMA to Report Genetic Variants of SARS-CoV-2
-
-
-
-
-
-
-
Twist Bioscience Corporation (TWST), CENTOGENE (CNTG) to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
-
-
-
-
-
-
-
Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
-
-
-
-
-
-
-
Twist Bioscience Corporation (TWST) , Biotia Receive U.S. FDA Emergency Use Authorization for First Hybridization Capture-Based Next-Generation Sequencing SARS-CoV-2 Assay
-
-
-
-
-
-
-
Twist Bioscience (TWST) Supplies Centers for Disease Control and Prevention with Custom SARS-CoV-2 Synthetic RNA Controls
-
-
-
-
-
-
-
Twist Bioscience Reports Second Quarter Fiscal 2020 Financial Results
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

